Drug details:
Molecular formula: C₁₄H₁₀FN₃O₄

Standard name: N-[(E)-(3-fluoro-2-hydroxyphenyl)methylideneamino]-4-nitrobenzamide

Curated SMILES: O=C(N/N=C/C1=CC=CC(F)=C1O)C1=CC=C([N+](=O)[O-])C=C1

Evidence for compound's anti-virulence activity:

Chlamydia
Related VF: TTSS (Type III secretion system)
Target: Not determined
Drug effect: Inhibits T3SS activity.
Max phase: Preclinical (in vitro)
Publication:
Dahlgren MK, et al., 2010. Statistical molecular design of a focused salicylidene acylhydrazide library and multivariate QSAR of inhibition of type III secretion in the Gram-negative bacterium Yersinia. Bioorg Med Chem 18(7):2686-703.